Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 81Leukemia 41Gastrointestinal Stromal Tumors 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Leukemia, Myeloid, Chronic-Phase 27Blast Crisis 13Neoplasms 10Neoplasm Metastasis 10Melanoma 10Brain Neoplasms 10Lung Neoplasms 9Prostatic Neoplasms 8Leukemia, Myeloid, Acute 8Gliosarcoma 8Glioblastoma 8Leukemia, Myeloid, Accelerated Phase 7Glioma 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 5Philadelphia Chromosome 5Oligodendroglioma 5Recurrence 4Primary Myelofibrosis 4Polycythemia Vera 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Breast Neoplasms 4Astrocytoma 4

Interventions

Filgrastim 13Peripheral Blood Stem Cell Transplantation 10Melphalan 9Ifosfamide 9Etoposide 9Cyclophosphamide 8Thiotepa 6Carboplatin 6Busulfan 6Radiotherapy 5Doxorubicin 5Vincristine 3Topotecan 3Temozolomide 3Docetaxel 3trioctyl phosphine oxide 2temsirolimus 2etoposide phosphate 2Transplantation 2Surgical Procedures, Operative 2Stem Cell Transplantation 2Radiotherapy, Intensity-Modulated 2Microarray Analysis 2Mesna 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Dexrazoxane 2Cisplatin 2Bone Marrow Transplantation 2Amifostine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive, Peripheral × Imatinib Mesylate × Clear all
NCT00062205 2010-02-09

Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor

City of Hope Medical Center

Phase 2 Completed
40 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡